Cargando…

GSG2 Promotes Development and Predicts Poor Prognosis of Ovarian Cancer

PURPOSE: Ovarian cancer is one of the most common malignant tumors in gynecology, whose treatment was seriously limited by the unclear understanding of molecular mechanism in disease development. GSG2, also known as Haspin, is a novel molecule found to be involved in human cancers. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yan, Liu, Yixuan, Zhu, Keyu, Ma, Xiaolu, Lu, Renquan, Zhang, Meiqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826093/ https://www.ncbi.nlm.nih.gov/pubmed/33500663 http://dx.doi.org/10.2147/CMAR.S274807

Ejemplares similares

Targeting endoplasmic reticulum stress signaling in ovarian cancer therapy
por: Yan, Tianqing, et al.
Publicado: (2023)

IFN-γ in ovarian tumor microenvironment upregulates HLA-E expression and predicts a poor prognosis
por: Zheng, Hui, et al.
Publicado: (2023)

TTK is a potential therapeutic target for cisplatin-resistant ovarian cancer
por: Liu, Yixuan, et al.
Publicado: (2021)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients
por: Zheng, Hui, et al.
Publicado: (2020)

GSG2 (Haspin) promotes development and progression of bladder cancer through targeting KIF15 (Kinase-12)
por: Chen, Yuhao, et al.
Publicado: (2020)

Cyclin H predicts the poor prognosis and promotes the proliferation of ovarian cancer
por: Peng, Chen, et al.
Publicado: (2020)

Identification of seven hypoxia-related genes signature and risk score models for predicting prognosis for ovarian cancer
por: Huang, Yan, et al.
Publicado: (2023)

CALD1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
por: Liu, Yixuan, et al.
Publicado: (2021)

Plasma exosomal caveolin-1 predicts Poor Prognosis in Ovarian Cancer
por: Yang, Lijuan, et al.
Publicado: (2021)

Knockdown of GSG2 inhibits prostate cancer progression in vitro and in vivo
por: Yu, Feng, et al.
Publicado: (2020)

Overexpression of RIPK4 Predicts Poor Prognosis and Promotes Metastasis in Ovarian Cancer
por: Liu, Shaoqiu, et al.
Publicado: (2021)

Overexpression of RASAL1 Indicates Poor Prognosis and Promotes Invasion of Ovarian Cancer
por: Chang, Rui-Xia, et al.
Publicado: (2019)

Predicting partition coefficients for the SAMPL7 physical property challenge using the ClassicalGSG method
por: Donyapour, Nazanin, et al.
Publicado: (2021)

Serology-Based Model for Personalized Epithelial Ovarian Cancer Risk Evaluation
por: Yan, Tianqing, et al.
Publicado: (2022)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

TPX2 promotes ovarian tumorigenesis by interacting with Lamin A/C and affecting its stability
por: Meng, Xin, et al.
Publicado: (2023)

Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer
por: Liu, Shuang, et al.
Publicado: (2018)

Overexpression of Growth-Related Oncogene-β Is Associated with Tumorigenesis, Metastasis, and Poor Prognosis in Ovarian Cancer
por: Ye, Qing, et al.
Publicado: (2015)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

The non‐coding RNA OTUB1‐isoform2 promotes ovarian tumour progression and predicts poor prognosis
por: Wang, Shunni, et al.
Publicado: (2018)

GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration
por: Zhou, Jun, et al.
Publicado: (2021)

MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3–phospho-BAD pathway
por: Guan, Xiaolin, et al.
Publicado: (2022)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2014)

PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer
por: Chen, Buze, et al.
Publicado: (2023)

Bioinformatic Analysis Reveals GSG2 as a Potential Target for Breast Cancer Therapy
por: Ye, Zheng, et al.
Publicado: (2019)

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
por: Zheng, Hui, et al.
Publicado: (2019)

Overexpression of Stathmin 1 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration in Ovarian Cancer
por: Nie, Lekai, et al.
Publicado: (2022)

Fault Detection for Wind Turbine Blade Bolts Based on GSG Combined with CS-LightGBM
por: Tang, Mingzhu, et al.
Publicado: (2022)

Epiphycan Predicts Poor Outcomes and Promotes Metastasis in Ovarian Cancer
por: Deng, Lu, et al.
Publicado: (2021)

Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer
por: Huang, Bihui, et al.
Publicado: (2016)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

Correction: YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients
por: Xia, Yan, et al.
Publicado: (2016)

Elafin is related to immune infiltration and could predict the poor prognosis in ovarian cancer
por: Lu, Weiyu, et al.
Publicado: (2023)

A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer
por: Cheng, Zhongping, et al.
Publicado: (2015)

GRHL2 Upregulation Predicts a Poor Prognosis and Promotes the Resistance of Serous Ovarian Cancer to Cisplatin
por: Nie, Yanting, et al.
Publicado: (2020)

NUF2 Expression Promotes Lung Adenocarcinoma Progression and Is Associated With Poor Prognosis
por: Jiang, Feng, et al.
Publicado: (2022)

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer
por: Wen, Ning, et al.
Publicado: (2014)

An epigenetic signature of adhesion molecules predicts poor prognosis of ovarian cancer patients
por: Chang, Ping-Ying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5ve4rsfglrq189q4m59b47oajj